Cycling and Treadmill With Dual Task for Parkinson's Disease Improvement
Cycling Induced Motor Cortex Plasticity and Functional Improvement -the Dual Task Evaluation Model for Parkinson Disease
1 other identifier
interventional
50
1 country
1
Brief Summary
Motor impairment in lower extremities is common in individuals with Parkinson disease (PD). Development sensitive test for early motor deviations is important. Conventional walking test cannot induce the PD related motor impairments, such as freezing of gait. Therefore, finding a safe substitute test to induce PD related motor impairments is important. Studies showed that working memory related dual task walking was a sensitive test for PD. However, the optimal cognitive test needs to be clarified. Studies also showed that the neuromuscular control mechanism of leg movements during cycling were similar to those during walking. Therefore, dual task cycling test is potential to be a safe and sensitive testing model. Studies showed that exercise could improve cognitive function and induce brain plasticity. Dual task exercise training was shown to be more effective than single task exercise training for older people to prevent fall. Whether the added cognitive task could improve to detriment brain plasticity in PD should be investigated. Transcranial magnetic stimulation can evaluate the motor cortex plasticity on-invasively and can evaluate the exercise induced brain plasticity. The purpose of this three-year project is to develop PD-sensitive. The purposes of the first year are to translate the dual task walking test to dual task cycling test, and to establish the reliability of the dual task cycling test. The purposes of the second year are to compare the motor cortex plasticity induced by single task cycling versus dual task cycling and to compare the difference response between PD and healthy control people. The purpose of the third year is to evaluate the effect of 8 week long term cycling training or treadmill training of individuals with PD on motor cortex plasticity, dual task performance, and ambulation ability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 7, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 11, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2018
CompletedFirst Submitted
Initial submission to the registry
March 26, 2024
CompletedFirst Posted
Study publicly available on registry
April 10, 2024
CompletedApril 10, 2024
April 1, 2024
1.8 years
March 26, 2024
April 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Walking Speed
The time taken by participants to walk a standardized distance, typically expressed in centimeters per second (cm/s).
Baseline, 4 weeks and 8 weeks
Step Length
The linear distance between the two ankles, typically expressed in centimeters(cm).
Baseline, 4 weeks and 8 weeks
Step Time
The duration taken for one complete step, measuring from foot-off of one foot to the next foot-off of the same foot, usually expressed in seconds.
Baseline, 4 weeks and 8 weeks
Power Spectral Density (PSD)
Quantifies the power of EEG signals within specific frequency bands (e.g., delta, theta, alpha, beta, and gamma) over a period.
Baseline, 4 weeks and 8 weeks.
Task Accuracy
The percentage of correct responses or actions made by participants in response to walking or cycling tasks.
Baseline, 4 weeks and 8 weeks.
Reaction Time
The duration between the onset of task start time and the participant's response to it, typically expressed in second (s).
Baseline, 4 weeks and 8 weeks.
Balance Performance
Measured by the duration the stance can be maintained, typically expressed second.
Baseline, 4 weeks and 8 weeks
Secondary Outcomes (6)
Double Support Time
Baseline, 4 weeks and 8 weeks
Single Support Time
Baseline, 4 weeks and 8 weeks
Swing Time
Baseline, 4 weeks and 8 weeks
Stance Time
Baseline, 4 weeks and 8 weeks
Cadence
Baseline, 4 weeks and 8 weeks
- +1 more secondary outcomes
Study Arms (5)
Stage 1:Healthy people
NO INTERVENTIONTo establish a baseline and ensure reliability, and to explore the relationship between dual-task gait performance and dual-task cycling
No Intervention: Stage 2:PD people
NO INTERVENTIONTo explore the relationship between dual-task gait and dual-task cycling performances in individuals with Parkinson's Disease (PD)
Stage 3:PD cycling training group
EXPERIMENTALCycling training conducted with cognitive tasks
Stage 3: PD treadmill training group
EXPERIMENTALTreadmill training conducted with cognitive tasks
Stage 3:PD Control group
NO INTERVENTIONControl group
Interventions
Cycling training conducted with cognitive tasks
Treadmill training conducted with cognitive tasks
Eligibility Criteria
You may not qualify if:
- Musculoskeletal injuries on legs.
- Osteoporosis.
- PD subjects:
- \- Clinical diagnosis of Parkinson disease.
- Musculoskeletal injuries on legs
- Osteoporosis.
- Any peripheral or central nervous system injury or disease patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chang Gung University
Taoyuan District, 333, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 26, 2024
First Posted
April 10, 2024
Study Start
December 7, 2015
Primary Completion
September 11, 2017
Study Completion
July 31, 2018
Last Updated
April 10, 2024
Record last verified: 2024-04